IP Library › Assignment 039197/0765
Patent Assignment
Reel/Frame 039197/0765

Change of Name

Recorded: 2016-07-06 Pages: 5
Assignor
TIGERCAT PHARMA, INC.
Executed: 2016-05-27
Assignee
MENLO THERAPEUTICS INC.
4085 CAMPBELL AVE., SUITE 200, MENLO PARK, CALIFORNIA, 94025
Covered Properties (6)
Use of Nk-1 Receptor Antagonists in Pruritus
Patent: 8,906,951 →
Application: 13/925,509 →
Publication: US 2014/0378521
Use of Nk-1 Receptor Antagonists in Pruritus
Patent: 9,198,898 →
Application: 14/312,942 →
Publication: US 2015/0057255
Use of Nk-1 Receptor Antagonist Serlopitant in Pruritus
Patent: 9,486,439 →
Application: 14/899,255 →
Publication: US 2016/0143882
Use of Nk-1 Receptor Antagonists in Pruritus
Patent: 9,381,188 →
Application: 14/922,684 →
Publication: US 2016/0038462
Use of Nk-1 Receptor Antagonists in Pruritus
Patent: 9,474,741 →
Application: 15/175,358 →
Publication: US 2016/0279100
Use of Nk-1 Receptor Antagonists in Pruritus
Application: 61/838,784 →
Related Assignments (9)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Jun 25, 2013
From: ZHANG, XIAOMING; SCHNIPPER, EDWARD F.; PERLMAN, ANDREW J.; LARRICK, JAMES W.
To: TIGERCAT PHARMA, INC.
Reel/Frame 030681/0886 →
Assignment of Assignor's Interest Jul 15, 2013
From: ZHANG, XIAOMING; SCHNIPPER, EDWARD F.; PERLMAN, ANDREW J.; LARRICK, JAMES W.
To: TIGERCAT PHARMA, INC.
Reel/Frame 030799/0441 →
Assignment of Assignor's Interest Aug 22, 2014
From: ZHANG, XIAOMING; SCHNIPPER, EDWARD F.; PERLMAN, ANDREW J.; LARRICK, JAMES W.
To: TIGERCAT PHARMA, INC.
Reel/Frame 033594/0099 →
Assignment of Assignor's Interest May 5, 2017
From: ZHANG, XIAOMING; SCHNIPPER, EDWARD F.; PERLMAN, ANDREW J.; LARRICK, JAMES W.
To: TIGERCAT PHARMA, INC.
Reel/Frame 042258/0517 →
Assignment of Assignor's Interest May 5, 2017
From: ZHANG, XIAOMING; SCHNIPPER, EDWARD F.; PERLMAN, ANDREW J.; LARRICK, JAMES W.
To: TIGERCAT PHARMA, INC.
Reel/Frame 042259/0057 →
Patent Security Agreement Mar 9, 2020
From: MENLO THERAPEUTICS INC.
To: PERCEPTIVE CREDIT HOLDINGS II, LP
Reel/Frame 052130/0980 →
Change of Name Dec 1, 2020
From: MENLO THERAPEUTICS INC.
To: VYNE THERAPEUTICS INC.
Reel/Frame 054558/0437 →
Change of Name Jan 20, 2021
From: MENLO THERAPEUTICS INC.
To: VYNE THERAPEUTICS INC.
Reel/Frame 055042/0165 →
Release of Security Interest Sep 20, 2021
From: PERCEPTIVE CREDIT HOLDINGS II, LP
To: VYNE THERAPEUTICS INC. (F/K/A MENLO THERAPEUTICS INC. AND SUCCESSOR-IN-INTEREST TO VYNE PHARMACEUTICALS LTD., F/K/A FOAMIX PHARMACEUTICALS LTD.)
Reel/Frame 057531/0986 →